Medical Director, Clinical Development, Solid Tumor Oncology
Regeneron Pharmaceuticals
Summary
At Regeneron, we use science and innovation to develop life-changing medicines for people with serious diseases. We are seeking a Medical Director, Clinical Sciences to join our Oncology team, supporting solid tumor drug development, including studies in prostate cancer. In this role, you will design clinical study concepts, oversee the medical and scientific supervision of clinical trials, and lead the Clinical Team to deliver high-quality program milestones, while collaborating with Clinical Project Managers, Clinical Trial Managers, and Therapeutic Area Program Managers. This position offers the opportunity to contribute to a fast-growing, science-driven organization making a meaningful difference to patients worldwide.
Job description
Build our future together
At Regeneron, we use science and innovation to develop life-changing medicines for people with serious diseases. We are seeking a Medical Director, Clinical Sciences to join our Oncology team, supporting solid tumor drug development, including studies in prostate cancer. In this role, you will design clinical study concepts, oversee the medical and scientific supervision of clinical trials, and lead the Clinical Team to deliver high-quality program milestones, while collaborating with Clinical Project Managers, Clinical Trial Managers, and Therapeutic Area Program Managers. This position offers the opportunity to contribute to a fast-growing, science-driven organization making a meaningful difference to patients worldwide.
When & where
- Location: Tarrytown, NY
- Travel: 10% to relevant conferences
Discover your role
- Define clinical trial-related goals and objectives
- Conduct literature and database research to inform trial design
- Collaborate with Clinical Project Managers, Clinical Trial Managers, and the Therapeutic Area Program Manager
- Contribute to program team meetings, scientific advisory boards, study steering committees, and data/safety monitoring meetings
- Lead and supervise the Clinical Team to deliver high-quality program milestones on schedule
- Build and maintain relationships with key study investigators
This role requires
- MD or MD/PhD with a minimum of 2 years of relevant research experience in industry or the academic research setting
- Oncology clinical fellowship training with translational and/or clinical research experience strongly preferred
Requirements
- MD or MD/PhD
- Minimum of 2 years of relevant research experience in industry or academic research setting
- Oncology clinical fellowship training with translational and/or clinical research experience strongly preferred
Benefits
- Annual bonuses
- Equity awards
- Pension or retirement benefits
- 401(k) company match
- Health and wellness programs
- Fitness centers
- Medical insurance
- Dental insurance
- Vision insurance
- Life and disability insurance
- Paid time off
- Family support benefits
Company overview
Regeneron Pharmaceuticals is a leading American biotechnology company founded in 1988 and headquartered in Tarrytown, New York. The company specializes in inventing, developing, and commercializing life-transforming medicines for people with serious diseases. Regeneron is renowned for its innovative antibody technologies and has developed several groundbreaking therapies, including EYLEA® for retinal diseases, DUPIXENT® for inflammatory conditions, and the COVID-19 antibody cocktail REGEN-COV®. The company operates with a strong focus on research and development across multiple therapeutic areas including ophthalmology, oncology, cardiovascular diseases, and rare genetic disorders. Regeneron's proprietary VelocImmune® technology platform enables the rapid generation of fully human monoclonal antibodies. With over 15,000 employees globally and annual revenues exceeding $14 billion, Regeneron has established itself as a major force in the biotechnology industry, consistently ranking among the top-performing pharmaceutical companies and maintaining a robust pipeline of investigational therapies.